Analysis showed lower CCR2 serum levels in the early AMD group compared to control subjects; unfortunately, these differences did not reach statistical significance (median (IQR): 2.1179 (1.79) ng/mL vs. 2.3465 (1.30) ng/mL, p = 0.094) (Figure 3). The gene discussed is CCR2; the disease is age-related macular degeneration.